Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
Dan H. Barouch(Beth Israel Deaconess Medical Center), Lindsey R. Baden(Brigham and Women's Hospital), Peter Abbink(Beth Israel Deaconess Medical Center), Nicole Frahm(Fred Hutch Cancer Center), M. Justin Iampietro(Janssen (Netherlands)), Mo Weijtens(Janssen (Netherlands)), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Jinyan Liu(Beth Israel Deaconess Medical Center), Holger Wenschuh, Maria Grazia Pau, Ulf Reimer, Amy W. Chung(The University of Melbourne), Michael S. Seaman(Beth Israel Deaconess Medical Center), M. Juliana McElrath(Fred Hutch Cancer Center), Anne-Sophie Dugast(Ragon Institute of MGH, MIT and Harvard), Jaap Goudsmit(Harvard University), Raphael Dolin(Beth Israel Deaconess Medical Center), Lauren Peter(Beth Israel Deaconess Medical Center), Ann Cheung(Wave Dragon (Denmark)), Stephen R. Walsh(Beth Israel Deaconess Medical Center)
Cited by 107
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k